Intelligent Medicament Dispenser System with Integrated Blockchain and AI

A novel system integrating a medicament dispenser with blockchain-based tracking, AI-powered usage monitoring, and IoT-enabled data transmission to ensure secure, accurate, and personalized medication management.

The original patent addressed the need for monitoring medicament dispenser usage, but it lacked the capability to securely track and analyze data. This new inventive concept solves this problem by incorporating blockchain, AI, and IoT technologies to provide a comprehensive and reliable medication management system.

The system comprises a medicament dispenser, an attachment component, and a blockchain-based tracking module. The attachment component includes a controller in communication with an acceleration sensor and an IoT-enabled wireless transceiver. The blockchain-based tracking module records and verifies usage data of the medicament dispenser. Additionally, the system can include an AI-powered usage monitoring attachment that analyzes usage patterns and provides personalized recommendations. The IoT-enabled monitoring attachment transmits usage data to a cloud-based server for analysis and tracking.

The integration of blockchain, AI, and IoT technologies with a medicament dispenser provides a novel and non-obvious solution for secure, accurate, and personalized medication management. The use of blockchain ensures tamper-proof tracking, while AI-powered analysis enables personalized recommendations. IoT-enabled data transmission facilitates real-time monitoring and tracking.

Alternative embodiments could include a wearable device for tracking medicament usage, a mobile application for receiving and analyzing usage data, or a cloud-based platform for aggregating and analyzing data from multiple users. Variations could also include different types of sensors, output devices, or communication protocols.

This inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of medication adherence, patient monitoring, and personalized medicine. The system could be marketed to pharmaceutical companies, healthcare providers, and patients with chronic conditions.